In a research letter, published in JAMA Oncology, researchers reported the incidence and outcomes of the severe adult respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with cancer who were treated at a tertiary cancer institution in Wuhan, China.1
The novel coronavirus disease 2019 (COVID-19) has been linked to SARS-CoV-2, which first occurred in Wuhan, Hubei in December 2019.
“Patients with cancer are often recalled to the hospital for treatment and monitoring, and hence, they may be at risk of contracting COVID-19,” the authors wrote. “Moreover, cancer treatments such as chemotherapy and radiotherapy are immunosuppressive.”
Researchers reviewed the medical records, including demographic, clinical, and treatment data, of 1,524 patients with cancer who were admitted to the Department of Radiation and Medical Oncology at Zhongnan Hospital of Wuhan…
